Good” data management practices used to mean “keep only what I need now,” but that mentality is a relic of the era when data ...

Recursion Pharmaceuticals ( RXRX +1.27%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Scientists at St. Jude Children's Research Hospital have created a database that provides updated predicted structures on a ...

Forget copyright. In the age of AI, the real IP isn’t code; it’s conviction. Tomorrow’s market leaders won’t own the most ...

In theory, the path forward is clear: interoperability, data-driven manufacturing, and smarter scheduling powered by AI. Imagine simply inputting what you want to make — dimensions, material — and the ...

Prevailing AI architectures are not moving the needle. We need new ideas. Google Research proposes NL (nested learning). Here ...

(11/4/25) The energy price index fell 3.7% in October, driven by a 5.1% decline in crude oil prices, partially offset by a 7.5% rise in U.S. natural gas prices. The non-energy price index changed ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...